AMTI insider filings
Applied Molecular Transport Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-12-29. Screen AMTI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AMTI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Applied Molecular Transport Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-12-29 | 4 | EPIQ Capital Group, LLC Boeding Chad EPQ LLC AMT PS EPQ LLC, AMTB PS EPQ LLC, AMTC PS | Other (J): 2,149,292 · Other (J): 3,394,948 · Other (J): 2,500,000 · Other (J): 293,278 | EDGAR |
| 2023-12-28 | 4 | VanDevender Aaron — Director | Disposition to issuer (D): 212,659 · Disposition to issuer (D): 15,395 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Schachner Holly Caren — Director | Disposition to issuer (D): 38,976 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Mahmood Tahir Ph.D. — Director | Disposition to issuer (D): 484,738 · Disposition to issuer (D): 3,208,307 · Disposition to issuer (D): 391,693 · Disposition to issuer (D): 164,000 (derivative) @ $0 · Disposition to issuer (D): 350,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Hants Brandon — CFO | Disposition to issuer (D): 301,225 · Disposition to issuer (D): 150,672 (derivative) @ $0 · Disposition to issuer (D): 4,328 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 76,000 (derivative) @ $0 · Disposition to issuer (D): 57,400 (derivative) @ $0 · +2 more | EDGAR |
| 2023-12-28 | 4 | Banard Charlene A. — Director | Disposition to issuer (D): 60,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Hants Brandon — CFO | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Cross Shawn — CEO & Chair of the Board, Director | Disposition to issuer (D): 545,499 · Disposition to issuer (D): 300,000 (derivative) @ $0 · Disposition to issuer (D): 63,000 (derivative) @ $0 · Disposition to issuer (D): 94,500 (derivative) @ $0 · Disposition to issuer (D): 84,000 (derivative) @ $0 · Disposition to issuer (D): 668,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Smither John W — Director | Disposition to issuer (D): 60,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2023-11-27 | 4 | Mahmood Tahir Ph.D. — Director | Sale (S): 286,320 @ $0.16 | EDGAR |
| 2023-11-27 | 4 | Hants Brandon — CFO | Sale (S): 61,494 @ $0.16 | EDGAR |
| 2023-11-24 | 4 | Cross Shawn — CEO & Chair of the Board, Director | Sale (S): 110,802 @ $0.16 | EDGAR |
| 2023-11-16 | 4 | Hants Brandon — CFO | Sale (S): 50,146 @ $0.16 | EDGAR |
| 2023-11-16 | 4 | Cross Shawn — CEO & Chair of the Board, Director | Sale (S): 90,447 @ $0.16 | EDGAR |
| 2023-10-10 | 4 | Mahmood Tahir Ph.D. — Director | Grant/award (A): 886,111 @ $0 · Sale (S): 184,442 @ $0.16 | EDGAR |
| 2023-10-04 | 4 | Mahmood Tahir Ph.D. — Director | Sale (S): 1,992 @ $0.24 · Sale (S): 2,245 @ $0.21 | EDGAR |
| 2023-10-04 | 4 | Hants Brandon — CFO | Sale (S): 1,643 @ $0.24 · Sale (S): 560 @ $0.24 · Sale (S): 718 @ $0.21 | EDGAR |
| 2023-10-04 | 4 | Cross Shawn — CEO & Chair of the Board, Director | Sale (S): 3,293 @ $0.24 · Sale (S): 536 @ $0.24 · Sale (S): 477 @ $0.24 · Sale (S): 1,253 @ $0.21 | EDGAR |
| 2023-10-02 | 4 | Hants Brandon — CFO | Grant/award (A): 491,111 @ $0 · Sale (S): 107,540 @ $0.16 | EDGAR |
| 2023-10-02 | 4 | Cross Shawn — CEO & Chair of the Board, Director | Grant/award (A): 886,111 @ $0 · Sale (S): 193,960 @ $0.16 | EDGAR |
| 2023-06-15 | 4 | VanDevender Aaron — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Schachner Holly Caren — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Mahmood Tahir Ph.D. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Banard Charlene A. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Smither John W — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Cross Shawn — CEO & Chair of the Board, Director | Grant/award (A): 668,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Mahmood Tahir Ph.D. — Chief Executive Officer, Director | Sale (S): 1,802 @ $0.50 | EDGAR |
| 2023-03-03 | 4 | Kanwar Bittoo — Chief Medical Officer | Sale (S): 539 @ $0.50 | EDGAR |
| 2023-03-03 | 4 | Hants Brandon — CFO | Sale (S): 504 @ $0.50 | EDGAR |
| 2023-03-03 | 4 | Cross Shawn — President & COO | Sale (S): 934 @ $0.50 | EDGAR |
| 2023-03-03 | 4 | Rich Douglas A. — Chief Technical Officer | Sale (S): 482 @ $0.50 | EDGAR |
| 2022-12-06 | 4 | Mrsny Randall Ph.D. — Director | Sale (S): 418 @ $1.05 | EDGAR |
| 2022-12-06 | 4 | Mahmood Tahir Ph.D. — Chief Executive Officer, Director | Sale (S): 1,772 @ $0 | EDGAR |
| 2022-12-06 | 4 | Kanwar Bittoo — Chief Medical Officer | Sale (S): 3,488 @ $1.05 | EDGAR |
| 2022-12-06 | 4 | Hants Brandon — CFO | Sale (S): 1,959 @ $1.05 | EDGAR |
| 2022-12-06 | 4 | Cross Shawn — President & COO | Sale (S): 3,893 @ $1.05 | EDGAR |
| 2022-12-06 | 4 | Rich Douglas A. — Chief Technical Officer | Sale (S): 4,229 @ $1.05 | EDGAR |
| 2022-11-29 | 4 | VanDevender Aaron — Director | Purchase (P): 100,000 @ $1.00 · Purchase (P): 50,000 @ $1.00 | EDGAR |
| 2022-09-06 | 4 | Mrsny Randall Ph.D. — Director | Sale (S): 404 @ $1.42 | EDGAR |
| 2022-09-06 | 4 | Mahmood Tahir Ph.D. — Chief Executive Officer, Director | Sale (S): 1,723 @ $1.42 | EDGAR |
| 2022-09-06 | 4 | Kanwar Bittoo — Chief Medical Officer | Sale (S): 503 @ $1.42 | EDGAR |
| 2022-09-06 | 4 | Hants Brandon — CFO | Sale (S): 462 @ $1.42 | EDGAR |
| 2022-09-06 | 4 | Cross Shawn — President & COO | Sale (S): 468 @ $1.42 · Sale (S): 416 @ $1.42 | EDGAR |
| 2022-09-06 | 4 | Rich Douglas A. — Chief Technical Officer | Sale (S): 448 @ $1.42 | EDGAR |
| 2022-06-03 | 4 | Mrsny Randall Ph.D. — Director | Sale (S): 319 @ $2.97 · Sale (S): 392 @ $3.04 | EDGAR |
| 2022-06-03 | 4 | Mahmood Tahir Ph.D. — Chief Executive Officer, Director | Sale (S): 1,382 @ $2.97 · Sale (S): 1,693 @ $3.04 | EDGAR |
| 2022-06-03 | 4 | Kanwar Bittoo — Chief Medical Officer | Sale (S): 1,792 @ $2.97 · Sale (S): 2,196 @ $3.04 | EDGAR |
| 2022-06-03 | 4 | Hants Brandon — CFO | Sale (S): 915 @ $2.97 · Sale (S): 1,122 @ $3.04 | EDGAR |
| 2022-06-03 | 4 | Cross Shawn — President & COO | Sale (S): 1,767 @ $2.97 · Sale (S): 2,166 @ $3.04 | EDGAR |
| 2022-06-03 | 4 | Rich Douglas A. — Chief Technical Officer | Sale (S): 2,123 @ $2.97 · Sale (S): 2,602 @ $3.04 | EDGAR |
Recent 8-K events — Applied Molecular Transport Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-12-27 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-12-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-09-27 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2023-09-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-14 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AMTI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs